3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Stress-induced tyrosine phosphorylation of RtcB modulates IRE1 activity and signaling outputs

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The tRNA ligase RtcB is tyrosine phosphorylated upon ER stress which in turn leads to modulation of XBP1 mRNA splicing and IRE1 signaling outputs.

          Abstract

          ER stress is mediated by three sensors and the most evolutionary conserved IRE1α signals through its cytosolic kinase and endoribonuclease (RNase) activities. IRE1α RNase activity can either catalyze the initial step of XBP1 mRNA unconventional splicing or degrade a number of RNAs through regulated IRE1-dependent decay. Until now, the biochemical and biological outputs of IRE1α RNase activity have been well documented; however, the precise mechanisms controlling whether IRE1α signaling is adaptive or pro-death (terminal) remain unclear. We investigated those mechanisms and hypothesized that XBP1 mRNA splicing and regulated IRE1-dependent decay activity could be co-regulated by the IRE1α RNase regulatory network. We identified that RtcB, the tRNA ligase responsible for XBP1 mRNA splicing, is tyrosine-phosphorylated by c-Abl and dephosphorylated by PTP1B. Moreover, we show that the phosphorylation of RtcB at Y306 perturbs RtcB interaction with IRE1α, thereby attenuating XBP1 mRNA splicing. Our results demonstrate that the IRE1α RNase regulatory network is dynamically fine-tuned by tyrosine kinases and phosphatases upon various stresses and that the extent of RtcB tyrosine phosphorylation determines cell adaptive or death outputs.

          Related collections

          Most cited references68

          • Record: found
          • Abstract: found
          • Article: not found

          UCSF Chimera--a visualization system for exploratory research and analysis.

          The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed. Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality. This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features. Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale molecular assemblies such as viral coats, and Collaboratory, which allows researchers to share a Chimera session interactively despite being at separate locales. Other extensions include Multalign Viewer, for showing multiple sequence alignments and associated structures; ViewDock, for screening docked ligand orientations; Movie, for replaying molecular dynamics trajectories; and Volume Viewer, for display and analysis of volumetric data. A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions. Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/. Copyright 2004 Wiley Periodicals, Inc.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Comparison of simple potential functions for simulating liquid water

                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: VisualizationRole: MethodologyRole: Writing—original draft
                Role: ConceptualizationRole: Formal analysisRole: ValidationRole: InvestigationRole: VisualizationRole: MethodologyRole: Writing—review and editing
                Role: Investigation
                Role: ConceptualizationRole: Investigation
                Role: VisualizationRole: Methodology
                Role: InvestigationRole: VisualizationRole: Methodology
                Role: Formal analysisRole: InvestigationRole: Visualization
                Role: Formal analysisRole: InvestigationRole: Visualization
                Role: Formal analysisRole: InvestigationRole: Visualization
                Role: Formal analysisRole: InvestigationRole: Visualization
                Role: Resources
                Role: ConceptualizationRole: ResourcesRole: Funding acquisition
                Role: ConceptualizationRole: Funding acquisition
                Role: Resources
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: SupervisionRole: Funding acquisitionRole: InvestigationRole: VisualizationRole: MethodologyRole: Writing—review and editing
                Role: ConceptualizationRole: Formal analysisRole: SupervisionRole: Funding acquisitionRole: ValidationRole: InvestigationRole: Project administrationRole: Writing—original draft, review, and editing
                Journal
                Life Sci Alliance
                Life Sci Alliance
                lsa
                lsa
                Life Science Alliance
                Life Science Alliance LLC
                2575-1077
                22 February 2022
                May 2022
                22 February 2022
                : 5
                : 5
                : e202201379
                Affiliations
                [1 ] INSERM U1242, University of Rennes, Rennes, France
                [2 ] Centre Eugène Marquis, Rennes, France
                [3 ] Centre National de la Recherche Scientifique, UMR7104, Illkirch, France
                [4 ] Institut National de la Santé et de la Recherche Médicale, U1258, Illkirch, France
                [5 ] Université de Strasbourg, Illkirch, France
                [6 ] Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Santiago, Chile
                [7 ] Center for Geroscience, Brain Health and Metabolism (GERO), Santiago, Chile
                [8 ] Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile
                [9 ] Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden
                [10 ] Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
                [11 ] Goodman Cancer Research Centre, McGill University, Montreal, Canada
                [12 ] Department of Biochemistry, McGill University, Montreal, Canada
                Author notes
                [*]

                Alexandra Papaioannou and Federica Centonze contributed equally to this work.

                Author information
                https://orcid.org/0000-0002-3470-284X
                https://orcid.org/0000-0002-2124-443X
                https://orcid.org/0000-0002-6204-3917
                https://orcid.org/0000-0002-4844-6234
                https://orcid.org/0000-0002-2553-7934
                https://orcid.org/0000-0001-5654-3109
                https://orcid.org/0000-0001-5855-4522
                Article
                LSA-2022-01379
                10.26508/lsa.202201379
                8899846
                35193953
                451e80fd-f735-45d2-840c-fcb308b9489b
                © 2022 Papaioannou et al.

                This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

                History
                : 20 January 2022
                : 27 January 2022
                : 31 January 2022
                Funding
                Funded by: Institut National du Cancer;
                Award ID: PLBIO2018, PLBIO2019, PLBIO2020
                Award Recipient :
                Funded by: SIRIC-ILIAD;
                Award Recipient :
                Funded by: Cancéropôle Grand Ouest;
                Award ID: Gliotreat
                Award Recipient :
                Funded by: Fondation pour la Recherche Médicale;
                Award ID: DEQ20180339169
                Award Recipient :
                Funded by: European Union (EU) H2020;
                Award ID: MSCA ITN-675448
                Award ID: MSCA RISE-734749
                Award Recipient :
                Funded by: Swedish Research Council;
                Award Recipient :
                Funded by: Swedish National Infrastructure for Computing;
                Award Recipient :
                Funded by: EU H2020;
                Award ID: MSCA ITN-675448
                Award Recipient :
                Funded by: Fondation ARC pour la recherche contre le cancer;
                Award Recipient :
                Funded by: Vinnova;
                Award Recipient :
                Categories
                Research Article
                Research Articles
                4

                Comments

                Comment on this article